Mestag Therapeutics
Mestag Therapeutics » Signaling a new era in immunotherapy
- Business Model
- B2B
- Website
- mestagtherapeutics.com
- Total Funding
- $85.0M
- Last Round
- $40.0M Growth EquityMar 2026
- Rounds
- 3
About
Mestag Therapeutics develops fibroblast immunology-based therapies for cancer and inflammatory diseases, with first-in-class programs in clinical development.
Summary
Mestag Therapeutics is a Biotech company. It has raised $85.0M in total across 3 rounds, most recently a $40.0M Growth Equity round in Mar 2026. Investors include Forbion Capital Partners, SV Health Investors and Johnson & Johnson Innovation.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...